Anaptysbio (ANAB) Other Non Operating Income (2016 - 2026)
Anaptysbio (ANAB) reported Other Non Operating Income of -$1000.0 for Q1 2026, down 100.05% on a YoY basis from $1.9 million in Q1 2025, and up 66.67% quarter-over-quarter from -$3000.0 in Q4 2025.
Anaptysbio (ANAB) Other Non Operating Income (2016 - 2026) Analysis & Trends
Anaptysbio has reported Other Non Operating Income for 11 years, with the latest figure at -$1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 100.05% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 83.89% YoY), and the FY2025 full-year result was $5.4 million, up 38685.71% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$1000.0, up from -$3000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $3.5 million in Q2 2025, with the low at -$5000.0 in Q3 2024.
- Historically, Other Non Operating Income has averaged $363533.3 across 5 years, with a median of $1000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non Operating Income tumbled 600.0% — and 2025, when it soared 95200.0%.
- Anaptysbio's Other Non Operating Income stood at -$4000.0 in 2022, then jumped by 50.0% to -$2000.0 in 2023, then soared by 1150.0% to $21000.0 in 2024, then slumped by 114.29% to -$3000.0 in 2025, then soared by 66.67% to -$1000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$1000.0 (Q1 2026), -$3000.0 (Q4 2025), and $3.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Anaptysbio | 1.66 Bn | 1.38 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Jun 30, 2025 | 3.53 Mn |
| Mar 31, 2025 | 1.90 Mn |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | -5,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | -4,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 33,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | -75,000.00 |
| Sep 30, 2020 | -56,000.00 |